Cognitive Impairment in Genetic Parkinson's Disease
- PMID: 35003622
- PMCID: PMC8739522
- DOI: 10.1155/2021/8610285
Cognitive Impairment in Genetic Parkinson's Disease
Abstract
Cognitive impairment is common in idiopathic Parkinson's disease (PD). Knowledge of the contribution of genetics to cognition in PD is increasing in the last decades. Monogenic forms of genetic PD show distinct cognitive profiles and rate of cognitive decline progression. Cognitive impairment is higher in GBA- and SNCA-associated PD, lower in Parkin- and PINK1-PD, and possibly milder in LRRK2-PD. In this review, we summarize data regarding cognitive function on clinical studies, neuroimaging, and biological markers of cognitive decline in autosomal dominant PD linked to mutations in LRRK2 and SNCA, autosomal recessive PD linked to Parkin and PINK1, and also PD linked to GBA mutations.
Copyright © 2021 A. Planas-Ballvé and D. Vilas.
Conflict of interest statement
The authors declare that there are no conflicts of interest regarding the publication of this study.
Similar articles
-
Cognitive and psychiatric symptoms in genetically determined Parkinson's disease: a systematic review.Eur J Neurol. 2020 Feb;27(2):229-234. doi: 10.1111/ene.14115. Epub 2019 Nov 28. Eur J Neurol. 2020. PMID: 31686421
-
Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.Neurosci Lett. 2016 Dec 2;635:67-70. doi: 10.1016/j.neulet.2016.10.040. Epub 2016 Oct 21. Neurosci Lett. 2016. PMID: 27777137
-
Nonmotor Signs in Genetic Forms of Parkinson's Disease.Int Rev Neurobiol. 2017;133:129-178. doi: 10.1016/bs.irn.2017.05.030. Epub 2017 Jul 13. Int Rev Neurobiol. 2017. PMID: 28802919 Review.
-
Genetics of Parkinson's disease--state of the art, 2013.Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S23-8. doi: 10.1016/S1353-8020(13)70009-9. Parkinsonism Relat Disord. 2014. PMID: 24262182 Review.
-
Down-regulation of B cell-related genes in peripheral blood leukocytes of Parkinson's disease patients with and without GBA mutations.Mol Genet Metab. 2016 Feb;117(2):179-85. doi: 10.1016/j.ymgme.2015.09.005. Epub 2015 Sep 14. Mol Genet Metab. 2016. PMID: 26410072
Cited by
-
Mitochondrial Dysfunction in Parkinson's Disease: A Contribution to Cognitive Impairment?Int J Mol Sci. 2024 Oct 25;25(21):11490. doi: 10.3390/ijms252111490. Int J Mol Sci. 2024. PMID: 39519043 Free PMC article. Review.
-
Genetics in parkinson's disease: From better disease understanding to machine learning based precision medicine.Front Mol Med. 2022 Oct 3;2:933383. doi: 10.3389/fmmed.2022.933383. eCollection 2022. Front Mol Med. 2022. PMID: 39086979 Free PMC article. Review.
-
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161. Cells. 2025. PMID: 40801594 Free PMC article. Review.
-
Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson's disease.NPJ Parkinsons Dis. 2023 Sep 12;9(1):132. doi: 10.1038/s41531-023-00572-3. NPJ Parkinsons Dis. 2023. PMID: 37699957 Free PMC article.
-
GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's disease.J Neurol. 2024 Jul;271(7):4392-4405. doi: 10.1007/s00415-024-12374-5. Epub 2024 Apr 24. J Neurol. 2024. PMID: 38656622
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous